Cargando…
Molecular Targets and Emerging Therapeutic Options for Uterine Leiomyosarcoma
Uterine leiomyosarcoma (uLMS) is an aggressive malignancy characterized by its early metastasis, high rates of recurrence, and poor prognosis. Multiple obstacles complicate the clinical management of uLMS. These include the fact that most uLMS are typically identified only after a woman has undergon...
Autores principales: | Miller, Heather, Ike, Chiemeka, Parma, Jennifer, Masand, Ramya P., Mach, Claire M., Anderson, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5046025/ https://www.ncbi.nlm.nih.gov/pubmed/27721667 http://dx.doi.org/10.1155/2016/7018106 |
Ejemplares similares
-
Evaluation of Hedgehog Pathway Inhibitors as a Therapeutic Option for Uterine Leiomyosarcoma Using the Xenograft Model
por: Garcia, Natalia, et al.
Publicado: (2021) -
Uterine Leiomyosarcoma
por: Byar, Katherine L., et al.
Publicado: (2022) -
Molecular Approach to Uterine Leiomyosarcoma: LMP2-Deficient Mice
as an Animal Model of Spontaneous Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2011) -
Status of the Current Treatment Options and Potential Future Targets in Uterine Leiomyosarcoma: A Review
por: Asano, Hiroshi, et al.
Publicado: (2022) -
Androgen receptor as a prognostic biomarker and therapeutic target in uterine leiomyosarcoma
por: Baek, Min-Hyun, et al.
Publicado: (2018)